| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesics, Opioid | 13 | 2026 | 470 | 5.920 |
Why?
|
| Point-of-Care Systems | 12 | 2024 | 204 | 5.510 |
Why?
|
| Sleep Apnea, Obstructive | 11 | 2025 | 233 | 5.230 |
Why?
|
| Adenoidectomy | 11 | 2025 | 84 | 4.800 |
Why?
|
| Tonsillectomy | 10 | 2025 | 111 | 4.760 |
Why?
|
| Anesthesiology | 10 | 2024 | 93 | 4.590 |
Why?
|
| Anesthesia | 13 | 2022 | 208 | 4.300 |
Why?
|
| Ultrasonography | 13 | 2024 | 961 | 3.850 |
Why?
|
| Perioperative Care | 9 | 2021 | 214 | 2.940 |
Why?
|
| Analgesics, Non-Narcotic | 4 | 2025 | 76 | 2.740 |
Why?
|
| Hypospadias | 4 | 2023 | 80 | 2.650 |
Why?
|
| Nerve Block | 5 | 2022 | 61 | 2.570 |
Why?
|
| Anesthetics | 5 | 2020 | 78 | 2.360 |
Why?
|
| Child | 56 | 2026 | 26092 | 2.030 |
Why?
|
| Preoperative Care | 6 | 2025 | 353 | 1.930 |
Why?
|
| Anesthesia, Caudal | 4 | 2020 | 15 | 1.900 |
Why?
|
| Anesthesia, General | 5 | 2025 | 128 | 1.860 |
Why?
|
| Ultrasonography, Interventional | 7 | 2024 | 202 | 1.820 |
Why?
|
| Anesthetics, Inhalation | 3 | 2022 | 44 | 1.610 |
Why?
|
| Thoracotomy | 3 | 2019 | 107 | 1.610 |
Why?
|
| Scoliosis | 3 | 2026 | 143 | 1.600 |
Why?
|
| Humans | 112 | 2026 | 130892 | 1.550 |
Why?
|
| Fentanyl | 2 | 2025 | 54 | 1.520 |
Why?
|
| Intraoperative Care | 2 | 2026 | 122 | 1.430 |
Why?
|
| Circumcision, Male | 2 | 2022 | 25 | 1.400 |
Why?
|
| Pediatrics | 4 | 2024 | 1229 | 1.370 |
Why?
|
| One-Lung Ventilation | 2 | 2021 | 5 | 1.310 |
Why?
|
| Acetaminophen | 4 | 2025 | 97 | 1.300 |
Why?
|
| Child, Preschool | 26 | 2025 | 14938 | 1.270 |
Why?
|
| Neurocognitive Disorders | 2 | 2020 | 74 | 1.250 |
Why?
|
| Phototherapy | 2 | 2021 | 37 | 1.250 |
Why?
|
| Methyl Ethers | 2 | 2022 | 23 | 1.240 |
Why?
|
| Hydrocodone | 3 | 2025 | 36 | 1.240 |
Why?
|
| Catheterization, Peripheral | 3 | 2022 | 129 | 1.240 |
Why?
|
| Fontan Procedure | 2 | 2022 | 189 | 1.180 |
Why?
|
| Hemodynamics | 5 | 2022 | 814 | 1.180 |
Why?
|
| Body Surface Area | 3 | 2013 | 36 | 1.170 |
Why?
|
| Chronic Pain | 2 | 2026 | 158 | 1.160 |
Why?
|
| Parents | 7 | 2024 | 1104 | 1.150 |
Why?
|
| Heart Defects, Congenital | 5 | 2021 | 1891 | 1.100 |
Why?
|
| Hypoxia | 3 | 2025 | 245 | 1.090 |
Why?
|
| Polysomnography | 4 | 2021 | 155 | 1.070 |
Why?
|
| Down Syndrome | 2 | 2022 | 233 | 1.060 |
Why?
|
| Intraoperative Complications | 2 | 2019 | 155 | 1.030 |
Why?
|
| Echocardiography | 6 | 2020 | 1138 | 1.030 |
Why?
|
| Peer Review, Research | 2 | 2017 | 45 | 0.980 |
Why?
|
| Obesity, Morbid | 3 | 2013 | 206 | 0.970 |
Why?
|
| Coronary Aneurysm | 2 | 2016 | 31 | 0.970 |
Why?
|
| Mediastinal Neoplasms | 2 | 2016 | 40 | 0.960 |
Why?
|
| Clinical Competence | 4 | 2024 | 1041 | 0.950 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2016 | 74 | 0.930 |
Why?
|
| Iatrogenic Disease | 1 | 2025 | 120 | 0.890 |
Why?
|
| Spinal Fusion | 1 | 2026 | 117 | 0.870 |
Why?
|
| Anesthesiologists | 3 | 2020 | 40 | 0.860 |
Why?
|
| Internship and Residency | 5 | 2022 | 1207 | 0.860 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2025 | 150 | 0.860 |
Why?
|
| Opioid-Related Disorders | 2 | 2025 | 293 | 0.850 |
Why?
|
| Credentialing | 1 | 2024 | 16 | 0.840 |
Why?
|
| Male | 38 | 2026 | 64798 | 0.830 |
Why?
|
| Hospitals, Pediatric | 4 | 2020 | 787 | 0.800 |
Why?
|
| Anesthesia, Epidural | 1 | 2022 | 18 | 0.760 |
Why?
|
| Lupus Erythematosus, Systemic | 8 | 2018 | 226 | 0.760 |
Why?
|
| Pain Measurement | 2 | 2021 | 351 | 0.740 |
Why?
|
| Hip Dislocation | 1 | 2022 | 36 | 0.740 |
Why?
|
| Antifibrinolytic Agents | 1 | 2022 | 48 | 0.740 |
Why?
|
| Pulmonary Atelectasis | 1 | 2021 | 13 | 0.730 |
Why?
|
| Tonsillitis | 1 | 2021 | 13 | 0.720 |
Why?
|
| Pulmonary Embolism | 1 | 2024 | 190 | 0.720 |
Why?
|
| Emergence Delirium | 1 | 2021 | 4 | 0.710 |
Why?
|
| Bronchodilator Agents | 1 | 2023 | 153 | 0.710 |
Why?
|
| Lung | 5 | 2021 | 1563 | 0.710 |
Why?
|
| Central Venous Catheters | 1 | 2022 | 51 | 0.700 |
Why?
|
| Incidence | 8 | 2026 | 3330 | 0.700 |
Why?
|
| Endoscopy | 2 | 2021 | 282 | 0.690 |
Why?
|
| Dexmedetomidine | 1 | 2021 | 47 | 0.690 |
Why?
|
| Penile Diseases | 1 | 2020 | 11 | 0.680 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 228 | 0.680 |
Why?
|
| Hypotension | 1 | 2022 | 184 | 0.670 |
Why?
|
| Urethral Diseases | 1 | 2020 | 17 | 0.670 |
Why?
|
| Urinary Fistula | 1 | 2020 | 19 | 0.670 |
Why?
|
| Pneumothorax | 1 | 2021 | 81 | 0.670 |
Why?
|
| Cutaneous Fistula | 1 | 2020 | 21 | 0.670 |
Why?
|
| Cohort Studies | 7 | 2026 | 5097 | 0.660 |
Why?
|
| Kasabach-Merritt Syndrome | 1 | 2020 | 15 | 0.660 |
Why?
|
| Catheterization, Central Venous | 1 | 2022 | 140 | 0.660 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2020 | 7 | 0.640 |
Why?
|
| Postal Service | 1 | 2020 | 11 | 0.640 |
Why?
|
| Infant | 13 | 2025 | 13206 | 0.640 |
Why?
|
| Sleep | 2 | 2021 | 373 | 0.630 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 457 | 0.630 |
Why?
|
| Heart-Assist Devices | 3 | 2017 | 989 | 0.620 |
Why?
|
| Airway Obstruction | 1 | 2021 | 176 | 0.620 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2021 | 105 | 0.610 |
Why?
|
| Hernia, Inguinal | 1 | 2019 | 41 | 0.610 |
Why?
|
| Epistaxis | 1 | 2019 | 11 | 0.610 |
Why?
|
| Laryngoscopy | 1 | 2021 | 157 | 0.610 |
Why?
|
| Pulmonary Blastoma | 1 | 2019 | 12 | 0.610 |
Why?
|
| Monitoring, Intraoperative | 2 | 2017 | 129 | 0.610 |
Why?
|
| Computers, Handheld | 1 | 2019 | 32 | 0.610 |
Why?
|
| Physical Examination | 1 | 2020 | 169 | 0.600 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 67 | 0.600 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 241 | 0.580 |
Why?
|
| Anesthesia, Dental | 1 | 2018 | 6 | 0.570 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 133 | 0.570 |
Why?
|
| Memory Disorders | 1 | 2020 | 207 | 0.570 |
Why?
|
| Databases, Genetic | 1 | 2021 | 499 | 0.570 |
Why?
|
| Female | 32 | 2026 | 70694 | 0.570 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 773 | 0.560 |
Why?
|
| Hyperbilirubinemia | 1 | 2018 | 41 | 0.550 |
Why?
|
| Embolism, Air | 1 | 2017 | 22 | 0.540 |
Why?
|
| Adolescent | 14 | 2026 | 20802 | 0.530 |
Why?
|
| Operating Rooms | 1 | 2018 | 76 | 0.530 |
Why?
|
| Drug Combinations | 3 | 2025 | 277 | 0.520 |
Why?
|
| Vascular System Injuries | 1 | 2018 | 58 | 0.520 |
Why?
|
| Penis | 3 | 2022 | 97 | 0.510 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 150 | 0.510 |
Why?
|
| Bias | 1 | 2017 | 144 | 0.510 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2017 | 48 | 0.510 |
Why?
|
| Heart Rate | 2 | 2020 | 577 | 0.500 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 232 | 0.500 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 417 | 0.500 |
Why?
|
| Airway Extubation | 1 | 2017 | 70 | 0.500 |
Why?
|
| Audiovisual Aids | 1 | 2016 | 23 | 0.500 |
Why?
|
| Music | 1 | 2016 | 18 | 0.500 |
Why?
|
| Fear | 1 | 2018 | 198 | 0.490 |
Why?
|
| Emergency Service, Hospital | 2 | 2025 | 1205 | 0.490 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 157 | 0.490 |
Why?
|
| Societies, Medical | 1 | 2020 | 790 | 0.480 |
Why?
|
| Cardiologists | 1 | 2016 | 26 | 0.480 |
Why?
|
| Dementia | 1 | 2021 | 433 | 0.480 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2017 | 110 | 0.480 |
Why?
|
| Transposition of Great Vessels | 1 | 2017 | 126 | 0.480 |
Why?
|
| Patient Discharge | 1 | 2020 | 505 | 0.480 |
Why?
|
| Anesthesia, Inhalation | 1 | 2015 | 12 | 0.480 |
Why?
|
| Computational Biology | 1 | 2021 | 871 | 0.470 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2022 | 1170 | 0.470 |
Why?
|
| Publications | 1 | 2015 | 36 | 0.470 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 169 | 0.460 |
Why?
|
| Drug Hypersensitivity | 1 | 2016 | 97 | 0.460 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 502 | 0.460 |
Why?
|
| Vena Cava, Superior | 1 | 2015 | 58 | 0.450 |
Why?
|
| Medical Order Entry Systems | 1 | 2016 | 108 | 0.450 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 72 | 0.450 |
Why?
|
| Postoperative Complications | 3 | 2023 | 3101 | 0.450 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 510 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 2849 | 0.440 |
Why?
|
| Ischemia | 1 | 2018 | 352 | 0.430 |
Why?
|
| Heart | 1 | 2019 | 671 | 0.430 |
Why?
|
| Tricuspid Valve | 1 | 2015 | 62 | 0.430 |
Why?
|
| Asthma | 1 | 2023 | 925 | 0.430 |
Why?
|
| Critical Care | 2 | 2019 | 676 | 0.430 |
Why?
|
| Treatment Outcome | 8 | 2023 | 12867 | 0.420 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 4013 | 0.420 |
Why?
|
| Neuralgia | 1 | 2014 | 51 | 0.410 |
Why?
|
| Catheter Ablation | 1 | 2017 | 312 | 0.410 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 321 | 0.410 |
Why?
|
| Biomedical Research | 2 | 2019 | 555 | 0.410 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 133 | 0.400 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2015 | 251 | 0.400 |
Why?
|
| Cardiac Catheterization | 1 | 2017 | 635 | 0.400 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2353 | 0.400 |
Why?
|
| Patient Safety | 2 | 2019 | 443 | 0.400 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2013 | 58 | 0.390 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 463 | 0.380 |
Why?
|
| Retrospective Studies | 9 | 2026 | 17497 | 0.370 |
Why?
|
| Anesthesia Recovery Period | 2 | 2021 | 23 | 0.360 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 1412 | 0.350 |
Why?
|
| Biomarkers | 1 | 2021 | 3376 | 0.350 |
Why?
|
| Heart Diseases | 3 | 2024 | 502 | 0.350 |
Why?
|
| Fibromyalgia | 1 | 2011 | 20 | 0.350 |
Why?
|
| Research Design | 1 | 2015 | 722 | 0.340 |
Why?
|
| Schools, Medical | 1 | 2012 | 110 | 0.340 |
Why?
|
| Anxiety | 1 | 2018 | 993 | 0.340 |
Why?
|
| Texas | 4 | 2025 | 3603 | 0.330 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8540 | 0.330 |
Why?
|
| Ibuprofen | 2 | 2021 | 41 | 0.330 |
Why?
|
| Stroke Volume | 3 | 2022 | 526 | 0.320 |
Why?
|
| Drug Administration Schedule | 3 | 2021 | 741 | 0.310 |
Why?
|
| Prospective Studies | 5 | 2022 | 6445 | 0.310 |
Why?
|
| Physicians | 2 | 2019 | 634 | 0.310 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2016 | 674 | 0.300 |
Why?
|
| Faculty, Medical | 1 | 2012 | 267 | 0.290 |
Why?
|
| Medication Errors | 2 | 2021 | 193 | 0.280 |
Why?
|
| Education, Medical | 1 | 2012 | 288 | 0.280 |
Why?
|
| Models, Biological | 1 | 2012 | 1388 | 0.270 |
Why?
|
| Students, Medical | 1 | 2012 | 344 | 0.260 |
Why?
|
| Catheters | 2 | 2019 | 83 | 0.260 |
Why?
|
| Pain Management | 2 | 2020 | 198 | 0.250 |
Why?
|
| Body Mass Index | 1 | 2012 | 1679 | 0.250 |
Why?
|
| Curriculum | 1 | 2012 | 779 | 0.250 |
Why?
|
| Intubation, Intratracheal | 2 | 2021 | 288 | 0.250 |
Why?
|
| STAT1 Transcription Factor | 2 | 2018 | 75 | 0.250 |
Why?
|
| Quantitative Trait Loci | 2 | 2018 | 307 | 0.240 |
Why?
|
| Surge Capacity | 1 | 2025 | 9 | 0.240 |
Why?
|
| Mass Casualty Incidents | 1 | 2025 | 17 | 0.230 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 709 | 0.230 |
Why?
|
| Sjogren's Syndrome | 2 | 2017 | 107 | 0.230 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2024 | 9 | 0.220 |
Why?
|
| United States | 8 | 2022 | 11732 | 0.220 |
Why?
|
| Alternative Splicing | 2 | 2024 | 313 | 0.220 |
Why?
|
| Oximetry | 1 | 2025 | 177 | 0.210 |
Why?
|
| Triage | 1 | 2025 | 153 | 0.210 |
Why?
|
| Wounds, Gunshot | 1 | 2025 | 142 | 0.210 |
Why?
|
| Trauma Centers | 1 | 2025 | 204 | 0.210 |
Why?
|
| Blood Transfusion | 2 | 2022 | 288 | 0.210 |
Why?
|
| Quality Improvement | 3 | 2019 | 700 | 0.200 |
Why?
|
| Length of Stay | 2 | 2026 | 1392 | 0.200 |
Why?
|
| Transfusion Medicine | 1 | 2022 | 2 | 0.200 |
Why?
|
| Pandemics | 2 | 2020 | 1156 | 0.200 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2023 | 51 | 0.190 |
Why?
|
| Cardiac Output | 2 | 2013 | 152 | 0.190 |
Why?
|
| Body Height | 2 | 2013 | 195 | 0.180 |
Why?
|
| Alleles | 5 | 2018 | 1707 | 0.180 |
Why?
|
| Urethra | 1 | 2022 | 85 | 0.180 |
Why?
|
| Exons | 1 | 2024 | 767 | 0.180 |
Why?
|
| Polypharmacy | 1 | 2021 | 36 | 0.180 |
Why?
|
| Blood Loss, Surgical | 1 | 2022 | 168 | 0.180 |
Why?
|
| Globulins | 1 | 2021 | 4 | 0.180 |
Why?
|
| STAT4 Transcription Factor | 2 | 2018 | 11 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2017 | 3398 | 0.170 |
Why?
|
| Erythrocyte Transfusion | 1 | 2022 | 142 | 0.170 |
Why?
|
| Hyperalgesia | 1 | 2021 | 26 | 0.170 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2021 | 63 | 0.170 |
Why?
|
| Fluid Therapy | 1 | 2022 | 145 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 896 | 0.170 |
Why?
|
| Dissent and Disputes | 1 | 2021 | 29 | 0.170 |
Why?
|
| Policy | 1 | 2021 | 35 | 0.170 |
Why?
|
| Analgesics | 1 | 2022 | 122 | 0.170 |
Why?
|
| Training Support | 1 | 2020 | 18 | 0.170 |
Why?
|
| Systems Biology | 1 | 2021 | 60 | 0.170 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 12 | 0.170 |
Why?
|
| Sutures | 1 | 2021 | 63 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 496 | 0.170 |
Why?
|
| Respiration | 1 | 2021 | 120 | 0.170 |
Why?
|
| Sacrococcygeal Region | 1 | 2020 | 37 | 0.170 |
Why?
|
| Blood Flow Velocity | 1 | 2022 | 423 | 0.160 |
Why?
|
| Adult | 6 | 2025 | 31503 | 0.160 |
Why?
|
| Palpation | 1 | 2020 | 18 | 0.160 |
Why?
|
| Anesthesia, Intravenous | 1 | 2020 | 7 | 0.160 |
Why?
|
| Accidents, Home | 1 | 2020 | 9 | 0.160 |
Why?
|
| Prescription Drug Diversion | 1 | 2020 | 6 | 0.160 |
Why?
|
| Computer Systems | 1 | 2020 | 36 | 0.160 |
Why?
|
| Hippocampus | 2 | 2025 | 795 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 5248 | 0.160 |
Why?
|
| Poisoning | 1 | 2020 | 16 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2020 | 51 | 0.160 |
Why?
|
| Needles | 1 | 2020 | 52 | 0.160 |
Why?
|
| Anesthetics, Intravenous | 1 | 2020 | 47 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 138 | 0.160 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 75 | 0.160 |
Why?
|
| Hip Fractures | 1 | 2020 | 68 | 0.150 |
Why?
|
| Operative Time | 1 | 2020 | 203 | 0.150 |
Why?
|
| HLA-DQ beta-Chains | 2 | 2016 | 19 | 0.150 |
Why?
|
| Single-Blind Method | 1 | 2020 | 240 | 0.150 |
Why?
|
| Research Support as Topic | 1 | 2019 | 61 | 0.150 |
Why?
|
| Spinal Nerves | 1 | 2019 | 5 | 0.150 |
Why?
|
| Thrombosis | 1 | 2024 | 493 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 134 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 188 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 161 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 609 | 0.150 |
Why?
|
| Fetal Therapies | 1 | 2020 | 85 | 0.150 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 57 | 0.150 |
Why?
|
| Body Weight | 2 | 2013 | 985 | 0.150 |
Why?
|
| Nasal Cavity | 1 | 2019 | 55 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2020 | 350 | 0.150 |
Why?
|
| Analgesia | 1 | 2019 | 43 | 0.150 |
Why?
|
| Risk Factors | 3 | 2022 | 10913 | 0.150 |
Why?
|
| Anesthesia, Cardiac Procedures | 1 | 2019 | 30 | 0.140 |
Why?
|
| Nose | 1 | 2019 | 112 | 0.140 |
Why?
|
| Research Personnel | 1 | 2019 | 136 | 0.140 |
Why?
|
| beta Karyopherins | 2 | 2016 | 16 | 0.140 |
Why?
|
| Checklist | 1 | 2019 | 100 | 0.140 |
Why?
|
| Philadelphia | 1 | 2018 | 29 | 0.140 |
Why?
|
| Otolaryngology | 1 | 2020 | 114 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 527 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 2 | 2016 | 45 | 0.140 |
Why?
|
| Learning | 1 | 2021 | 369 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2019 | 151 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2022 | 1441 | 0.130 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1631 | 0.130 |
Why?
|
| Peer Review | 1 | 2017 | 36 | 0.130 |
Why?
|
| Bilirubin | 1 | 2018 | 126 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 831 | 0.130 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 1164 | 0.130 |
Why?
|
| Professional-Family Relations | 1 | 2018 | 95 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
|
| Cyanosis | 1 | 2017 | 42 | 0.130 |
Why?
|
| Radial Artery | 1 | 2017 | 34 | 0.130 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 69 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2020 | 819 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2017 | 113 | 0.130 |
Why?
|
| Haplotypes | 5 | 2016 | 543 | 0.120 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2016 | 15 | 0.120 |
Why?
|
| HLA-C Antigens | 1 | 2016 | 11 | 0.120 |
Why?
|
| HLA-B Antigens | 1 | 2016 | 30 | 0.120 |
Why?
|
| Surgeons | 1 | 2020 | 285 | 0.120 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 152 | 0.120 |
Why?
|
| Myasthenia Gravis | 1 | 2016 | 69 | 0.120 |
Why?
|
| Fetal Diseases | 1 | 2020 | 459 | 0.120 |
Why?
|
| Risk | 1 | 2017 | 738 | 0.120 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 90 | 0.120 |
Why?
|
| Watchful Waiting | 1 | 2016 | 74 | 0.120 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 134 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 365 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2015 | 11 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2019 | 333 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 794 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2866 | 0.110 |
Why?
|
| Receptors, Complement 3d | 1 | 2014 | 7 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 339 | 0.110 |
Why?
|
| Heroin Dependence | 1 | 2015 | 57 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 180 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2285 | 0.110 |
Why?
|
| Antibodies, Antinuclear | 1 | 2014 | 31 | 0.110 |
Why?
|
| Shock | 1 | 2015 | 96 | 0.110 |
Why?
|
| Prosthesis Design | 1 | 2017 | 608 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 460 | 0.110 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 1834 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2017 | 399 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 483 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 434 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 1217 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2014 | 92 | 0.100 |
Why?
|
| Mice | 5 | 2025 | 18445 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4682 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 441 | 0.100 |
Why?
|
| Radiography | 1 | 2015 | 755 | 0.100 |
Why?
|
| Water | 1 | 2014 | 188 | 0.100 |
Why?
|
| Disease Management | 1 | 2017 | 559 | 0.100 |
Why?
|
| Catheterization | 1 | 2014 | 232 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2016 | 284 | 0.100 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3669 | 0.090 |
Why?
|
| Comorbidity | 1 | 2017 | 1588 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 643 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 300 | 0.090 |
Why?
|
| Time Factors | 1 | 2021 | 6260 | 0.090 |
Why?
|
| Animals | 6 | 2025 | 34278 | 0.090 |
Why?
|
| Young Adult | 3 | 2025 | 10043 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1472 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2013 | 364 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1899 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2013 | 683 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2015 | 980 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2013 | 517 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2012 | 305 | 0.080 |
Why?
|
| Genotype | 4 | 2016 | 2651 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1397 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2016 | 3431 | 0.070 |
Why?
|
| Prognosis | 1 | 2016 | 4926 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 991 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2557 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2024 | 280 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2025 | 223 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2015 | 306 | 0.050 |
Why?
|
| Autoimmune Diseases | 2 | 2016 | 275 | 0.050 |
Why?
|
| Middle Aged | 3 | 2025 | 28670 | 0.050 |
Why?
|
| Dosage Forms | 1 | 2021 | 9 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 852 | 0.050 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 18 | 0.050 |
Why?
|
| Drug Storage | 1 | 2021 | 18 | 0.050 |
Why?
|
| Pamphlets | 1 | 2021 | 23 | 0.050 |
Why?
|
| Aged | 2 | 2025 | 21112 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2021 | 39 | 0.040 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 54 | 0.040 |
Why?
|
| Cricetulus | 1 | 2021 | 88 | 0.040 |
Why?
|
| CHO Cells | 1 | 2021 | 149 | 0.040 |
Why?
|
| Parental Consent | 1 | 2021 | 22 | 0.040 |
Why?
|
| Health Literacy | 1 | 2021 | 77 | 0.040 |
Why?
|
| Fascia | 1 | 2020 | 14 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 124 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 550 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2020 | 58 | 0.040 |
Why?
|
| Language | 1 | 2021 | 214 | 0.040 |
Why?
|
| Financial Management | 1 | 2019 | 13 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 146 | 0.040 |
Why?
|
| Zika Virus | 1 | 2021 | 155 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 791 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 234 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 1124 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 437 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 343 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1312 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 1958 | 0.030 |
Why?
|
| Chile | 1 | 2016 | 25 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 21 | 0.030 |
Why?
|
| Argentina | 1 | 2016 | 55 | 0.030 |
Why?
|
| Turkey | 1 | 2016 | 64 | 0.030 |
Why?
|
| Peru | 1 | 2016 | 56 | 0.030 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2016 | 62 | 0.030 |
Why?
|
| HLA-DQ Antigens | 1 | 2016 | 22 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2016 | 27 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2016 | 35 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2016 | 67 | 0.030 |
Why?
|
| Wavelet Analysis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 2016 | 77 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2016 | 52 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 4752 | 0.030 |
Why?
|
| Caregivers | 1 | 2021 | 582 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 109 | 0.030 |
Why?
|
| Trisomy | 1 | 2016 | 112 | 0.030 |
Why?
|
| Automation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 198 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2016 | 108 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1771 | 0.030 |
Why?
|
| Pressure | 1 | 2015 | 125 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 153 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 152 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 155 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 322 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2016 | 319 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 123 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 2014 | 10 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1167 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2014 | 23 | 0.030 |
Why?
|
| Arteries | 1 | 2015 | 209 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2017 | 285 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 439 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 631 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 755 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 53 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 749 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 6870 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2020 | 998 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2014 | 79 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2015 | 171 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 834 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1233 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 804 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1495 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1708 | 0.020 |
Why?
|
| Genome, Human | 1 | 2016 | 1331 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2681 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1444 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7544 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 3679 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 2433 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4497 | 0.010 |
Why?
|